Shares of Hypera S.A. (OTCMKTS:HYPMY – Get Free Report) hit a new 52-week low during trading on Thursday . The company traded as low as $3.77 and last traded at $3.77, with a volume of 27890 shares traded. The stock had previously closed at $4.21.
Hypera Stock Down 10.5 %
The firm has a market cap of $2.39 billion, a price-to-earnings ratio of 9.04 and a beta of 1.04. The company’s fifty day moving average is $4.97 and its 200 day moving average is $5.28.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
See Also
- Five stocks we like better than Hypera
- Quiet Period Expirations Explained
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- What Are Dividend Challengers?
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
